RLYB-332

N/A

Report date: 2024/07/05 14:18:52

Base Information

Drug NameRLYB-332

Drug Alias NameRLYB-332RLYB332

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionTransmembrane protease serine 6 inhibitors

TargetsTransmembrane protease serine 6

Therapy Area/IndicationsIron Overload

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesRallybio Corp

China Registration ClassN/A

Active CompaniesRallybio Corp

Inactive CompaniesN/A

Active IndicationsIron Overload

Inactive IndicationsN/A

ATC CodeN/A